The 1 Event That Sent NewLink Genetics Corporation Soaring 25% in September — The Motley Fool — Good StockInvest


What happened Shares of NewLink Genetics (NASDAQ:NLNK), a small-cap clinical-stage drug developer focused on therapies to treat cancer, skyrocketed by 25% in September, according to data from S&P Global Market Intelligence. The clear reason for the move higher is tied to an early month press release that updated trial data from an ongoing phase 2…

via The 1 Event That Sent NewLink Genetics Corporation Soaring 25% in September — The Motley Fool — Good StockInvest

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s